• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUMINEX CORPORATION ARIES FLU A/B & RSV ASSAY; ARIES® FLU A/B & RSV ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUMINEX CORPORATION ARIES FLU A/B & RSV ASSAY; ARIES® FLU A/B & RSV ASSAY Back to Search Results
Model Number 50-10020
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Dyspnea (1816); Fatigue (1849); Hypoxia (1918); Nausea (1970); Chills (2191); Test Result (2695); Cough (4457)
Event Date 01/08/2021
Event Type  Death  
Manufacturer Narrative
The cause of death was confirmed as cardiopulmonary arrest secondary to covid-19 pneumonia and influenza b.The result of the aries® flu a/b & rsv assay was influenza b.Based the fact that the aries result was influenza b and the patient died from influenza b, there is no indication of a false positive result and therefore no product malfunction.
 
Event Description
Customer reported influenza b positive on aries flu a/b and rsv assay.Aries: influenza b positive sample was not repeated on another platform, there is no discrepancy to report.On 1/22/2021 luminex was made aware that there was a patient death involved the patient tested positive for both covid and flu b, the flu b was resulted from the aries assay.The patient was admitted due to fatigue, sob, cough, chills, nausea, hypoxia.The aries flu b result was released to the physician on (b)(6) 2021 @ 2055.The patient also tested positive for covid off-site a week prior (approx.(b)(6) 2020).Customer did not know which platform was used for covid testing or which genes were detected.The patient was receiving following the treatments prior to aries result, ceftriaxone and doxycycline ((b)(6) 2021), remdesivir ((b)(6) 2021), azithromycin; the addition of tamiflu was added ((b)(6) 2021) after the aries result was released.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARIES FLU A/B & RSV ASSAY
Type of Device
ARIES® FLU A/B & RSV ASSAY
Manufacturer (Section D)
LUMINEX CORPORATION
12212 technology blvd #130
austin TX 78727
Manufacturer Contact
wendy ricker
12212 technology blvd
austin, TX 78727
6082038936
MDR Report Key11231005
MDR Text Key228710447
Report Number1650733-2021-00002
Device Sequence Number1
Product Code OCC
UDI-Device Identifier00840487100158
UDI-Public00840487100158
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K161220
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date09/10/2021
Device Model Number50-10020
Device Catalogue Number50-10020
Device Lot NumberAB1226A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/16/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-